Inactive Instrument

Highlights Mylan N.V. Nasdaq

Equities

MYL

NL0011031208

Highlights

Unlock all the news: Be the first to know and act before the market!

Viatris Says US Department of Justice's Antitrust Division No Longer Considers Mylan Subject of Investigation	05:41pm	MT
US DOJ drops Viatris unit Mylan from industry-wide antitrust probe	05:40pm	RE
US DOJ informs Viatris' Mylan is no longer part of antitrust investigation	05:11pm	RE
European Commission Conditionally Approves Cooper-Viatris Deal	27/06	MT
IQuest Enterprises Private Limited acquired API operations of Viatris in India.	03/06	CI
Ex-dividend day	23/05	FA
Tranche Update on Viatris Inc.'s Equity Buyback Plan announced on February 28, 2022.	09/05	CI
Viatris Inc. Announces Quarterly Dividend, Payable on June 14, 2024	09/05	CI
Viatris Inc. Revises Earnings Guidance for the Year 2024	09/05	CI
Viatris' Q1 Adjusted Earnings, Revenue Decrease; 2024 Outlook Reduced	09/05	MT
(VTRS) VIATRIS Forecasts Fiscal Year 2024 Revenue Range $14.98B - $15.48B	09/05	MT
Earnings Flash (VTRS) VIATRIS Posts Q1 Revenue $3.66B, vs. Street Est of $3.69B	09/05	MT
Earnings Flash (VTRS) VIATRIS Reports Q1 EPS $0.67, vs. Street Est of $0.67	09/05	MT
Viatris Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05	CI
Viatris' Proposed Femoston, Duphaston UK Rights Divestment Being Considered, CMA Says	18/04	MT
UK Regulator to Consider Undertakings for Theramex-Viatris Deal	18/04	MT
Viatris Launches New Generic Treatment Option for Multiple Sclerosis in Canada	15/04	MT
Viatris Inc. Announces Launch of First Bioequivalent Generic Version of Copaxone 20 mg/mL Once-Daily in Canada	15/04	CI
Atomo Diagnostics Wins AU$570,000 HIV Self-Tests Order	15/04	MT
Ocuphire Pharma, Inc. Announces Global License Agreement with Viatris Inc	11/04	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Mylan N.V. Nasdaq

Equities

MYL

NL0011031208

Highlights

Filters